Diabetes is associated with a higher incidence of short-term mortality risk and readmission in patients who undergo surgical but not transcatheter aortic valve replacement
Diabetes increases the risk of short-term mortality in sAVR but not TAVR. Moreover, the incidence of 30-day mortality and readmission is lower in TAVR compared with TAVR among patients with diabetes.
Authors
- Amin Jayyousi (ORCID: https://orcid.org/0000-0003-3174-3037)
- Soha R. Dargham (ORCID: https://orcid.org/0000-0003-2695-6564)
- Jassim Al Suwaidi (ORCID: https://orcid.org/0000-0002-5299-9106)
- Charbel Abi Khalil (ORCID: https://orcid.org/0000-0002-1428-6324)
- Khalifa Bsheish
- A de Souza
Institutions
- Johns Hopkins University (US)
- Cornell University (US)
- Johns Hopkins Medicine (US)
- Rochester General Hospital (US)
- Weill Cornell Medical College in Qatar (QA)
- Weill Cornell Medicine (US)
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- Open Heart
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/openhrt-2024-003019
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78